title: Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integrase.
abstract: We have examined the activities of HIV-1 integrase on substrates containing mismatches, composed of deoxyuridine at different positions in either the processed or nonprocessed strand of viral DNA, within and near the conserved CA dinucleotide of the U5 end of the HIV-1 LTR. Substitution in the processed strand of either the C or A of the CA dinucleotide or of the G 5' to the CA reduced strand transfer six-, three- and seven-fold respectively. 3'-processing was also reduced by substitution at the GC but not at the A. Substitution in the nonprocessed strand of the G nucleotide at the processing site abolished strand transfer while substitution of the T had no effect. DNA binding of HIV-1 integrase was not affected by deoxyuridine substitutions. Deoxyuridine substitution outside the trinucleotide remained compatible with enzyme activity. Enzymatically generated abasic sites were created at each mismatch to determine the effect of a missing base on integrase activity. Consistent with the deoxyuridine mismatch observations, 3'-processing and strand transfer were abolished when the abasic site was substituted for either of the nucleotides of the GCA trinucleotide. Integrase was, however, able to tolerate mismatches within this trinucleotide during the disintegration reaction. Taken together, these results suggest that base-mismatched or base-deleted substrates, which can be created by the proofreading-deficient HIV-1 RT, can be tolerated by HIV-1 integrase when located outside of the GCA trinucleotide at the U5 end of the LTR.
authors.affiliation: Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: A
authors.initials: A
authors.lastname: Mazumder
authors.forename: Y
authors.initials: Y
authors.lastname: Pommier
mesh_terms: D001483:Base Sequence; D045647:DNA Glycosylases; D004254:DNA Nucleotidyltransferases / Q000378:metabolism*; D004279:DNA, Viral / Q000235:genetics / Q000378:metabolism; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase; D043223:Deoxyribonuclease IV (Phage T4-Induced); D003854:Deoxyribonucleotides / Q000235:genetics / Q000378:metabolism; D003857:Deoxyuridine / Q000378:metabolism; D016325:HIV Long Terminal Repeat / Q000235:genetics; D015497:HIV-1 / Q000201:enzymology*; D006801:Humans; D019426:Integrases; D008190:Lyases / Q000378:metabolism; D008969:Molecular Sequence Data; D009699:N-Glycosyl Hydrolases / Q000378:metabolism; D009692:Nucleic Acid Heteroduplexes / Q000235:genetics / Q000378:metabolism*; D017354:Point Mutation; D011119:Polynucleotides / Q000378:metabolism*; D051981:Uracil-DNA Glycosidase; D016662:Virus Integration / Q000235:genetics*
chemical_list: D004279:DNA, Viral; D003854:Deoxyribonucleotides; D009692:Nucleic Acid Heteroduplexes; D011119:Polynucleotides; C001790:apyrimidinic acid; D004254:DNA Nucleotidyltransferases; D019426:Integrases; D043223:Deoxyribonuclease IV (Phage T4-Induced); D045647:DNA Glycosylases; D009699:N-Glycosyl Hydrolases; D051981:Uracil-DNA Glycosidase; D008190:Lyases; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase; D003857:Deoxyuridine